Results of CRS and Debulking in PMP Patients
This trial is active, not recruiting.
|Start date||September 1993|
|Trial identifier||NCT01427101, 2007/073-PMP-Andréasson|
The aim of this study was to compare debulking surgery and cytoreductive surgery in patients with Pseudomyxoma Peritonei with respect to efficacy and safety.
morbidity and mortality
time frame: 90 days
Male or female participants from 20 years up to 80 years old.
Inclusion Criteria: - Patients with radiology histopathology finding of Pseudomyxoma Peritonei Exclusion Criteria: - Preformance status WHO >2 and histopathology shows other origin then Pseudomyxoma Peritonei
|Official title||Comparison Between Cyotreductive Surgery and Debulking Surgery in Patients With Pseudomyxoma Peritonei|
|Principal investigator||Haile Mahteme, MD, PhD|
Call for more information